Are Patients at Risk for Recurrent Disease Activity After Switching From Remicade® to Remsima®? An Observational Study
暂无分享，去创建一个
T. Missotten | M. V. van Velthoven | V. Dalm | P. M. van Hagen | A. Thiadens | M. Hermans | M. Schreurs | W. Dik | Laixi Xue | R. Kuijpers | K. van Bilsen | P. van Daele | P. van Biezen | J. van Laar | P. V. van Daele | J. V. van Laar | P. van Hagen | Laixi Xue | V. H. Dalm